NDAORAL SUSPENSIONTABLETPriority Review
Lifecycle
Pre-Launch
Data completeness
1/8 — Limited
Priority Review
DOLUTEGRAVIR SODIUM (dolutegravir sodium) by Viatris (2) is fixed-dose combination of the hiv‑1 antiretroviral agents abacavir, dolutegravir, and lamivudine [see microbiology ()].
Drug data last refreshed 5h ago · AI intelligence enriched 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Dolutegravir sodium is a fixed-dose combination integrase strand transfer inhibitor (INSTI) combined with two nucleoside reverse transcriptase inhibitors (NRTIs): abacavir and lamivudine. It is used to treat HIV-1 infection in adults and adolescents. This combination works by blocking HIV replication through multiple mechanisms of action targeting different stages of viral life cycle.
PRE_LAUNCH
Pre-launch product offers opportunity to build commercial infrastructure and market positioning in the competitive HIV treatment landscape.
Mechanism of Action
fixed-dose combination of the HIV‑1 antiretroviral agents abacavir, dolutegravir, and lamivudine [see Microbiology ()].
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Joining the Dolutegravir sodium team at Viatris provides entry into the high-value HIV therapeutic market with exposure to launch commercialization strategy. Career growth depends on successful market penetration and differentiation against entrenched competitors.
Brand ManagerMedical Science Liaison
Worked on DOLUTEGRAVIR SODIUM at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.